default author photo

Francesco Montorsi

Università Vita-Salute San Raffaele

Via Olgettina 58

Milan, 20132

Italy

Università Vita-Salute San Raffaele - Department of Urology

Milan

Italy

Vita-Salute San Raffaele University, San Raffaele Hospital, Urological Research Institute

Italy

SCHOLARLY PAPERS

2

DOWNLOADS

112

TOTAL CITATIONS

12

Scholarly Papers (2)

1.

Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer

Number of pages: 52 Posted: 15 Sep 2021
Dxige Research Inc., Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Northwestern University - Department of Urology, Federal University of Parana (UFPR) - Bioinformatics and Systems Biology Laboratory, French League Against Cancer - Tumor Identity Cards Program, French League Against Cancer - Tumor Identity Cards Program, ImmunoMind Inc., ImmunoMind Inc., Northwestern University - Department of Pathology, Università Vita-Salute San Raffaele - Department of Medical Oncology, Oncology Institute of Southern Switzerland - Service of Medical Oncology, Università Vita-Salute San RaffaeleUniversità Vita-Salute San Raffaele - Department of Urology, Queen Mary University of London - Centre for Experimental Cancer Medicine, Università Vita-Salute San Raffaele - Department of Medical Oncology and Northwestern University, Feinberg School of Medicine - Departments of Urology, and Biochemistry and Molecular GeneticsNorthwestern University - Department of Urology
Downloads 60 (961,006)

Abstract:

Loading...

muscle-invasive bladder cancer, checkpoint immunotherapy, single-sample classifier, Digital Spatial Profiling, Connectivity Map, immune cell deconvolution, BCR, RNA-Seq, scRNA-Seq

2.

Pembrolizumab as Neoadjuvant Therapy Preceding Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Group, Phase 2 Study

Number of pages: 30 Posted: 15 Sep 2018
Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Università Vita-Salute San Raffaele, Fondazione IRCCS Istituto Nazionale dei Tumori, Università Vita-Salute San Raffaele, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Fondazione IRCCS Istituto Nazionale dei Tumori, Università Vita-Salute San Raffaele, Fondazione IRCCS Istituto Nazionale dei Tumori, Università Vita-Salute San Raffaele, Università Vita-Salute San Raffaele, Vita-Salute San Raffaele University, San Raffaele Hospital, Urological Research Institute, Fondazione IRCCS Istituto Nazionale dei Tumori, Foundation Medicine Inc., Foundation Medicine Inc., Foundation Medicine Inc., Foundation Medicine Inc., Fondazione IRCCS Istituto Nazionale dei Tumori and Università Vita-Salute San RaffaeleUniversità Vita-Salute San Raffaele - Department of Urology
Downloads 52 (1,041,696)
Citation 12

Abstract:

Loading...